Author:
Barnabas Ruanne V.,Baeten Jared M.,Lingappa Jairam R.,Thomas Katherine K.,Hughes James P.,Mugo Nelly R.,Delany-Moretlwe Sinead,Gray Glenda,Rees Helen,Mujugira Andrew,Ronald Allan,Stevens Wendy,Kapiga Saidi,Wald Anna,Celum Connie
Funder
National Institutes of Health
NIH
the Bill and Melinda Gates Foundation
National Institute of Allergy and Infectious Diseases
National Cancer Institute
National Institute of Mental Health
National Institute on Drug Abuse
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of General Medical Sciences
National Institute of Diabetes & Digestive & Kidney Diseases
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Immunology and Allergy
Reference14 articles.
1. Herpes Zoster
2. Herpes Zoster Vaccine Effectiveness against Incident Herpes Zoster and Post-herpetic Neuralgia in an Older US Population: A Cohort Study
3. Benson C , Hua L , Anderson JW et al . Zostavax is generally safe and immunogenic in HIV+ adults virologically suppressed on ART: results of a phase 2, randomized, double-blind, placebo-controlled trial. Presented at: 19th Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, 2012.
4. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed 16 May 2014.
5. Herpes Zoster and Human Immunodeficiency Virus Infection
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献